Table 2 Treatment-related adverse events
Disease stage | ||||||
|---|---|---|---|---|---|---|
ND (n = 1599) | HD (n = 1408) | PD (n = 336) | ||||
ADRs, n (%) | SADRs, n (%) | ADRs, n (%) | SADRs, n (%) | ADRs, n (%) | SADRs, n (%) | |
Any | 49 (3.06) | 21 (1.31) | 59 (4.19) | 35 (2.48) | 15 (4.46) | 6 (1.78) |
Number of cases that had ≥ 2 ADRs | ||||||
Hypertension | 15 (0.93) | 0 | 16 (1.13) | 1 (0.07) | 5 (1.48) | 0 |
Increased BP | 1 (0.06) | 0 | 4 (0.28) | 0 | 1 (0.29) | 0 |
IDA | 4 (0.25) | 0 | 3 (0.21) | 0 | 0 | 0 |
Anemia | 2 (0.12) | 2 (0.12) | 10 (0.71) | 10 (0.71) | 2 (0.59) | 2 (0.59) |
Cerebral infarction | 1 (0.06) | 1 (0.06) | 4 (0.28) | 4 (0.28) | 0 | 0 |
Shunt occlusion | 1 (0.06) | 1 (0.06) | 5 (0.35) | 5 (0.35) | 0 | 0 |
Cerebral hemorrhage | 0 | 0 | 2 (0.14) | 2 (0.14) | 0 | 0 |
Subdural hematoma | 2 (0.12) | 2 (0.12) | 0 | 0 | 0 | 0 |
Diabetic nephropathy | 2 (0.12) | 2 (0.12) | 0 | 0 | 0 | 0 |
Increased Hb | 2 (0.12) | 0 | 0 | 0 | 0 | 0 |
Decreased platelets | 2 (0.12) | 0 | 1 (0.07) | 1 (0.07) | 0 | 0 |
Decreased appetite | 0 | 0 | 2 (0.14) | 2 (0.14) | 0 | 0 |